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Understanding the molecular pathogenesis of Clostridioides difficile has relied on the use of 26 
ermB-based mutagens in erythromycin-sensitive strains. However, the repeated subcultures 27 
required to isolate sensitive variants can lead to the acquisition of ancillary mutations that 28 
affect phenotype, including virulence. CRISPR-Cas9 allows the direct selection of mutants, 29 
reducing the number of subcultures and thereby minimising the likelihood of acquiring 30 
additional mutations. Accordingly, CRISPR-Cas9 was used to sequentially remove from the 31 
C. difficile 630 reference strain (NCTC 13307) two ermB genes and pyrE. The genomes of 32 
the strains generated (630Δerm* and 630Δerm*ΔpyrE, respectively) contained no ancillary 33 
mutations compared to the NCTC 13307 parental strain, making these strains the preferred 34 
option where erythromycin-sensitive 630 strains are required. Intriguingly, the cas9 gene of 35 
the plasmid used contained a proximal frameshift mutation. Despite this, the frequency of 36 
mutant isolation was high (96% and 89% for ermB and pyrE, respectively) indicating that a 37 
functional Cas9 is still being produced. Re-initiation of translation from an internal AUG start 38 
codon would produce a foreshortened protein lacking a RuvCI nucleolytic domain, 39 
effectively a ‘nickase’. The mutation allowed cas9 to be cloned downstream of the strong Pthl 40 
promoter. It may find application elsewhere where the use of strong, constitutive promoters is 41 
preferred. 42 
  43 
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Introduction 44 
Clostridioides difficile (formerly Clostridium difficile 1) is a Gram-positive, anaerobic, 45 
endospore-forming bacterium, which is the leading cause of antibiotic-associated diarrhoea 46 
worldwide. C. difficile associated infection (CDI) is characterised by a range of disease 47 
symptoms ranging from mild, self-limiting diarrhoea to the potentially fatal 48 
pseudomembranous colitis (PMC) and places a significant burden on healthcare facilities. 49 
The principle virulence factors are the two large, glucosylating toxins A and B 2. Efforts to 50 
identify and characterise those other factors important in CDI have centred on genomic 51 
studies and the application of mutagenic gene tools 2. 52 
The first C. difficile genome sequence determined was that of the erythromycin (Em) 53 
resistant (R), outbreak strain, 630 3 4. Its genome contained two sequence identical erm(B) 54 
genes, termed erm1(B) and erm2(B), which formed part of the mobilizable, non-conjugative 55 
transposon Tn5398 5. To enable the use of EmR genes as selectable markers in available gene 56 
tools, sensitive (S) variants of strain 630 were required. These were independently isolated by 57 
two laboratories using serial passage in antibiotic-free media. Mullany and co-workers (UCL, 58 
London, UK) performed 30 such subcultures to isolate 630Δerm 6, whilst the Rood laboratory 59 
(Monash, Australia) performed an undisclosed number of subcultures to generate 630E 7. 60 
Both 630Δerm and 630E possess an identical 2.4 kb deletion in Tn5398 that entirely removed 61 
erm2(B) together with the gene encoding CD630_2008, a predicted plasmid-partitioning 62 
protein.  63 
The availability of 630Δerm and 630E allowed the use of ClosTron and allelic exchange 64 
tools which capitalised on the use of ermB genes to generate insertional 8 or clean deletion 65 
mutants 9. However, it became apparent that the phenotypic behaviour of 630 toxin mutants, 66 
for instance, was influenced by which EmS strain was employed as the progenitor 2,10. It 67 
subsequently transpired that during their derivation, multiple single nucleotide 68 
polymorphisms (SNPs) and Indels (Insertion/deletions) had accumulated within their 69 
genomes compared to the parental 630 strain 11. Furthermore, phenotypic comparisons of 70 
630Δerm and 630E revealed the latter grew more slowly than the former and to a lower final 71 
cell density, produced lower toxin titres and was less virulent in the hamster model of C. 72 
difficile infection 11.  73 
It is likely that the ancillary mutants that arose in 630Δerm and 630E were a consequence 74 
of the repeated subcultures needed to isolate a spontaneous EmS strain. This could be avoided 75 
by direct deletion of ermB from the 630 genome. Whilst this can be relatively easily achieved 76 
through the use of allelic exchange in combination with counter selection markers 12, the 77 
desired mutants may not be directly selected. Rather, a sequential process is used in which 78 
single crossover integrants are first selected on media supplemented with an appropriate 79 
antibiotic. Following their purification, these cells are then plated on selective media 80 
containing the necessary counter selective agent to identify the desired double crossover 81 
mutant 9. One consequence of the necessary repeated passage through single cell, clonal 82 
selection steps is the increased probability of isolating SNPs and Indels. A more rapid route 83 
to mutant generation would be preferable.  84 
The recent exemplification of CRISPR-Cas9 mutagenesis in clostridia 13,14,15, including C. 85 
difficile 16, 17, offers the facility to directly select double crossover mutants in the absence of 86 
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traditional counter selection markers. The associated reduction in the number of steps needed 87 
to isolate mutants should minimise the risk of isolating variants in which secondary mutations 88 
have arisen. To test this assumption we sought to implement our previously developed 89 
CRISPR-Cas9 system 14 in C. difficile and recreate a strain 630 variant sensitive to Em. Our 90 
design took the opportunity to delete both copies of ermB, thereby reducing the risk of 91 
reversion to EmR. During the course of this work, we isolated a CRISPR-Cas9 variant 92 
(trCas9) which, in the configuration used, facilitated its deployment in mutant generation.  93 
 94 
Results  95 
Modularisation of a CRISPR-Cas9 Vector. We have previously constructed a CRISPR-96 
Cas9 vector for use in a number of industrially relevant clostridia, including Clostridium 97 
ljungdahlii 14. As C. difficile is also an acetogen 18, we based our vector on the latter system. 98 
To build in utility we first modularised the vector to conform to the standardised, 99 
pMTL80000 modular vector system in which the application module (between the SbfI and 100 
AscI restriction enzyme sites) became the components required for CRISPR-Cas9 genome 101 
editing. The CRISPR-specific components were divided into the following sub-modules; A) 102 
nuclease, B) guide RNA, and C) editing template. Submodules A and B are flanked with 103 
unique 6-8 nucleotide restriction sites; SbfI and XbaI for submodule A, and XbaI, and AsiSI 104 
for submodule B. The latter also contains a SalI site between the guide RNA promoter and 105 
the seed region of the guide RNA, enabling high throughput assembly methods to rapidly 106 
exchange guide targeting loci. Due to submodule C containing relatively long (>1500 bp) 107 
sequences, the 8 nucleotide AsiSI and AscI restriction sites were selected to reduce the 108 
likelihood of unwanted occurrence of recognition sequences within the homology arms that 109 
comprise the editing template. 110 
 111 
Initially the vector pMTLcas-pta previously shown to generate a pyrE knockout in C. 112 
ljungdahlii 14 was adapted to the modular format 19. Early iterations of the vector were 113 
designed to incorporate an alternative restriction site, MauBI, between submodules B and C, 114 
however, this was later substituted to AsiSI as commercially available MauBI proved 115 
relatively inefficient in DNA cleavage (METHODS). The final pMTL40000 vector design 116 
can be seen in Fig. 1. For pMTL431511-CLAU-pyrE, the pCB102 Gram-positive replicon 117 
was used, along with the CatP selective marker, and ColE1 + tra Gram-negative replicon 118 
module. The CRISPR-specific application module comprises (A) Pthl controlling the 119 
expression of cas9 RNA (B) the ParaE promoter controlling the expression of sgRNA 120 
containing the pyrE targeting seed region, and (C) the homology cassette consists of 1 kB 121 
regions immediately up- and down-stream of the pyrE gene. 122 
 123 
 124 
 125 
Implementation of the modular CRISPR vector in C. difficile. Following modularisation 126 
of the CRISPR vector the plasmid was adapted for use in C. difficile. The nuclease selected 127 
for submodule A remained the cas9 gene from Streptococcus pyogenes under the control of 128 
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the strong thiolase promoter from Clostridium acetobutylicum as it is known to function 129 
effectively in C. difficile 8,19. For submodule B, the sgRNA cassette was placed under the 130 
control of the native C. difficile Toxin B promoter PtcdB, and an editing template for 131 
homologous recombination comprising approximately 1 kb up- and down-stream genomic 132 
regions flanking the desired 3.6 kb deletion region within Tn5398 (Fig. 2A) made up 133 
submodule C. To thoroughly test our CRISPR-Cas9 genome editing plasmid, and since guide 134 
RNA prediction methods are in their infancy, we generated three CRISPR-Cas9 vectors 135 
targeting the CD630_2008 gene in Tn5398, with each containing a different 20 nucleotide 136 
crRNA sequence (Fig. 2B & 2C) from those identified using the Benchling CRISPR guide 137 
design tool 20. These vectors, pMTL431521-CDF-2008A, pMTL431521-CDF-2008B and 138 
pMTL431521-CDF-2008C, were conjugated into our C. difficile 630 strain (CRG856) and 139 
the resulting thiamphenicol-resistant transconjugants which appeared after 48-72 hours were 140 
screened via colony PCR (Fig. 3). Of the 25 colonies screened, all but one generated a 2.44 141 
kb-sized product signifying the deletion of both erm(B) genes from Tn5398 with an editing 142 
efficiency of 96%. Eleven of these 25 PCR screens also showed bands at 6.088 kb and/or 143 
3.682 kb indicating the presence of wild-type 630 or 630Δerm Tn5398 sequence, 144 
respectively, whilst thirteen appeared as pure mutants. From these thirteen pure mutants, 145 
three independently generated strains, one from each CRISPR-Cas9 vector, were carried 146 
forward for plasmid loss, with the subsequent thiamphenicol-sensitive strains designated as 147 
630Δerm*.  148 
 149 
The cas9 gene of pMTL431521 contains a frame shift. In parallel to the generation of the 150 
erm(B) deletion variants, the entire nucleotide sequence of the plasmids used were 151 
determined using appropriate primers and Sanger sequencing. Unexpectedly, a single adenine 152 
base insertion within a poly-A region starting at nucleotide position 130 was discovered 153 
which resulted in a frameshift mutation. This same single base insertion was also found in the 154 
parental plasmid, pMTLcas-pta 14. Closer inspection of the region of sequence affected 155 
identified an AUG start codon some 135 nucleotides 3’ to the frameshift that was preceded 156 
by a sequencing bearing some resemblance to a RBS which would allow a truncated Cas9 157 
(trCas9) protein lacking 87 amino acids from the N-terminal end of Cas9 to be produced (Fig. 158 
4). The deleted Cas9 domain encompasses a RuvCI nucleolytic domain. The trCas9 produced 159 
would, therefore, most likely represent a ‘nickase’ variant of Cas9 which produces single-160 
strand nicks instead of DSBs. Cas9 nickase variants have been previously shown to be highly 161 
effective for genome editing in clostridia 13. 162 
 163 
 164 
Generation of 630Δerm*ΔpyrE. Having successfully demonstrated that our CRISPR-Cas9 165 
system was effective, despite the premature termination of the Cas9 polypeptide, we sought 166 
to further validate this system via the truncation of pyrE in each of our independent 167 
630Δerm* strains. An editing template encompassing approximately 1 kb up- and down-168 
stream of the 234 bp to be deleted from the 3’-end of the pyrE gene was constructed via SOE 169 
PCR and cloned into pMTL431521-CDF-2008A. HiFi assembly was again used to insert the 170 
three chosen crRNA sequences (Fig. 2D & 2E) from the 16 identified within the 234 bp 171 
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target region, generating vectors pMTL431521-CDF-pyrE1, pMTL431521-CDF-pyrE2 and 172 
pMTL431521-CDF-pyrE3. These vectors were transferred into each of the independent 173 
630Δerm* strains and 12 resulting thiamphenicol-resistant colonies from each conjugation 174 
were colony PCR screened for the desired deletion (Fig. 4). Whilst 32/36 colonies (89%) 175 
contained the 1.822 kb band indicative of this deletion, over half of these also contained a 176 
2.056 kb band consistent with the wild-type pyrE sequence. Previous CRISPR-Cas9 studies 177 
have reported that the isolation of pure mutants following such mixed phenotypes from PCR 178 
screens can be improved via additional streaking of the mixed strains on selective media 14. 179 
Therefore, we streaked all 36 colonies onto the same BHIS media supplemented with 180 
thiamphenicol twice more, performing colony PCR screens after each round of streaking 181 
(Fig. 5). After the first round of screening, 13/36 colonies were pure mutant with a further 182 
19/36 displaying a mixed wild-type and mutant phenotype. The number of pure mutants 183 
obtained increased to 21 after one additional streak, and to 32 after a third round of screening, 184 
confirming the observations by Huang et al. 14. Three independently generated pure pyrE-185 
truncated mutants were sub-cultured to lose the plasmid and named CRG 630Δerm*ΔpyrE 186 
#1-3. 187 
  188 
Whole genome sequencing of CRG 630Δerm* strains. We next performed Illumina whole 189 
genome sequencing of our independent CRG 630Δerm* mutants, along with the parental 190 
CRG 630 strain, to assess whether any genomic variants had accumulated in these strains 191 
during CRISPR-Cas9 mutagenesis. Illumina reads from each strain were aligned to the 630 192 
reference sequence AM180355.1 (Table S1). Whilst we were able to show that no additional 193 
mutations relative to the parental strain were present, we detected 17 variants present in each 194 
of our CRG 630 strains (parent and mutants) compared to the published reference genome. 195 
These variants consisted of 13 single nucleotide polymorphisms, three point insertions and a 196 
21-nucleotide deletion from the CD630_26850 ORF resulting in an in-frame deletion of 197 
seven amino acids from the mature protein. Searches for conserved protein domains within 198 
the amino acid sequence of CD630_26850 identified C-terminal SpoIIE and serine 199 
phosphatase domains. This 21-nt internal deletion within CD630_26850 was confirmed via 200 
PCR and Sanger sequencing with flanking primers in our CRG 630 strain and its progeny, but 201 
was not observed in our 630Δerm strain.  202 
To investigate the effects of this 21-nt deletion, or indeed any of the other variants, on the 203 
ability of our CRG 630 strain and its progeny to form heat-resistant spores over five days we 204 
performed a rate of sporulation assay (Fig. S1). Development of heat-resistant CFU for CRG 205 
630 and its progeny was lower, yet comparable, with that of 630Δerm and this difference was 206 
not statistically significant. Furthermore, there was no significant difference between our 207 
CRG 630 strain and the 630Δerm* derivatives indicating the deletion of the 3.6 kb genomic 208 
region containing both erm(B) genes had no effect upon the proficiency of these strains to 209 
develop heat-resistant spores.  210 
 211 
Regeneration of 630Δerm* and 630Δerm*ΔpyrE. From these whole genome sequencing 212 
results it was clear that our aim of generating a new EmS C. difficile 630 strain free from 213 
genomic variants had not been achieved due to an accumulation of ancillary mutants, and in 214 
particular the 21-bp deletion. Hence, we sought to repeat our CRISPR-Cas9 mutagenesis in a 215 
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newly acquired reference strain of C. difficile 630 from the NCTC culture collection (NCTC 216 
13307; ‘NCTC 630’). Accordingly, vectors pMTL431521-CDF-2008A, pMTL431521-CDF-217 
2008B and pMTL431521-CDF-2008C were conjugated into NCTC 630 and, as before, three 218 
independent 630Δerm* strains lacking both erm(B) genes were obtained, one from each 219 
conjugation. Similarly, for the regeneration of 630Δerm*ΔpyrE, vectors pMTL431521-CDF-220 
pyrE1, pMTL431521-CDF-pyrE2 and pMTL431521-CDF-pyrE3 were conjugated into the 221 
three 630Δerm* replicates and the desired truncation of pyrE observed in each case (Fig. S2). 222 
Phenotypic characterisation of NCTC 630Δerm* and 630Δerm*ΔpyrE strains 223 
 224 
Having regenerated 630Δerm* and 630Δerm*ΔpyrE mutants in the NCTC 630 strain, we 225 
next confirmed the expected phenotypes of these strains by assessing growth after plating on 226 
appropriate media (Fig. 6). All three independent 630Δerm* mutants were unable to grow on 227 
BHIS media supplemented with 10 μg.ml-1 Em. Furthermore, only the three 630Δerm*ΔpyrE 228 
strains were able to grow on CDMM supplemented with uracil and 5-FOA, as in the parental 229 
NCTC 630 strain the product of the pyrE gene converts 5-FOA into the toxic compound 5-230 
FUMP. To determine whether the deletion of both ermB genes from C. difficile 630 is 231 
sufficient to prevent the reversion to EmR exhibited by 630Δerm, we conducted serial 232 
passages of the parental 630 strain, 630Δerm* mutants and 630Δerm in antibiotic-free, liquid 233 
media. After thirty such passages, neither 630Δerm nor 630Δerm* exhibited a reversion to 234 
EmR which would allow these strains to grow on BHIS media supplemented with 10 μg.ml-1 235 
Em. We then determined the minimum inhibitory concentration of these strains to Em using 236 
the broth microdilution method (Fig. 7). The MIC of both 630Δerm and 630Δerm* strains 237 
was determined to be 2 µg.ml-1, whilst the NCTC 630 strain was resistant up to 64 μg.ml-1, 238 
the highest Em concentration tested.  239 
 240 
 241 
Whole genome sequencing of NCTC 630Δerm* and 630Δerm*ΔpyrE strains. We then 242 
performed Illumina sequencing on our new NCTC 630 strain as well as each triplicate of the 243 
630Δerm* and 630Δerm*ΔpyrE progeny. All genomic variants identified in these strains 244 
relative to the CP010905.2 reference sequence are outlined in Table S2 in Supplementary 245 
Information. The NCTC 630 strain was found to contain three genomic variants relative to 246 
the CP010905.2 reference sequence, consisting of a single adenosine base insertion in a non-247 
coding region downstream of argS, and two non-synonymous SNPs in the rpoB and perR 248 
genes. Unsurprisingly, these variants were present in all of the subsequent mutants. Of the 249 
three triplicate 630Δerm*ΔpyrE strains, one (replicate #3) had accumulated no SNPs nor 250 
indels after the two rounds of CRISPR-Cas9 mutagenesis. Interestingly, in both rounds of 251 
mutagenesis this strain required the fewest passages to confirm the loss of the CRISPR 252 
plasmid. Meanwhile, replicates #1 and #2, which required up to four additional passages to 253 
confirm loss of the CRISPR, were found to have accumulated one and two SNPs, 254 
respectively. 630Δerm*ΔpyrE replicate #1 contained an additional non-synonymous SNP in 255 
perR, which encodes a peroxide-responsive repressor, whilst 630Δerm*ΔpyrE replicate #2 256 
contained two additional non-synonymous SNPs; one in CDIF630_00864 encoding a putative 257 
lipoprotein and another introducing a premature stop codon in eftA3, which encodes an 258 
electron transfer flavoprotein alpha subunit. Each of these variants occurred during the first 259 
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round of CRISPR-Cas9 mutagenesis to generate the 630Δerm* strains. Thus, no variants 260 
were accumulated in any of our triplicates during the second round of CRISPR-Cas9 genome 261 
editing to obtain the 630Δerm*ΔpyrE mutants.  262 
We then aligned our NCTC 630 sequence data against other 630 and 630Δerm reference 263 
sequences available from the NCBI database to see how this NCTC sequence compares to 264 
other 630 strains (Table S3). The NCTC 630 strain sequenced in this study is most similar to 265 
that sequenced by Riedel et al. 21, (CP010905.2) who obtained their strain from the DSM 266 
culture collection (DSM 27543). As this DSM strain was acquired from the NCTC, the three 267 
variants we observe in our NCTC 630 strain most likely arose in the intervening time 268 
between transfer from the NCTC and sequencing of the DSM strain. Meanwhile, we 269 
observed 16 conflicts (13 SNPs, 3 point insertions) when comparing our NCTC 630 sequence 270 
with that of the 630 sequence from Sebaihia et al. 3, only five of which are also present in 271 
both 630Δerm sequences. This suggests that the first 630 strain sequenced (AM180355.1) 272 
had diverged from a progenitor strain from which 630Δerm was generated, as we would 273 
expect all variants called in AM180355.1 to be present in the 630Δerm sequences.  274 
 275 
Discussion 276 
In this study, we used CRISPR-Cas9 genome editing to generate 630Δerm*, a fully EmS 277 
variant of a C. difficile reference strain 630 (NCTC 13307), by removing both ermB genes 278 
present on the mobilizable transposon Tn5398. The CRISPR-Cas9 system developed in this 279 
study was then further exemplified via the generation of 630Δerm*ΔpyrE, a truncated pyrE 280 
deletion mutant compatible with the pre-existing allele-coupled exchange methodology. 281 
Crucially, replicates of each mutant were obtained lacking any SNPs or Indels which can 282 
arise during mutagenesis. This genome editing, performed in triplicate for each deletion 283 
target using three separate plasmids with unique crRNA retargeting sequences, was observed 284 
to be highly efficient in each instance. Observed editing efficiencies in this study of 96% for 285 
630Δerm* and 89% for 630Δerm*ΔpyrE.  286 
The efficiency of mutant generation observed here represents a higher frequency than 287 
obtained using the aTet-inducible system of McAllister and coworkers 16 who described 288 
mutant generation in pyrE and selD at frequencies of 50 and 20%, respectively. A similar 289 
system based on a lactose inducible promoter was used to ‘knock-out’ spo0A (100%) and 290 
‘knock-in’ a fluorescent PpFbFPm reporter gene 17. Mutant colonies of the latter could not 291 
initially be detected and required that the primary transconjugants were subcultured overnight 292 
in liquid media and re-plated to single colonies before the presence of mutants could be 293 
demonstrated. In the experiment described, 80% were mutants. Interestingly, in both cases 294 
16,17 mutants were obtained in the absence of inducer indicating that neither promoter system 295 
(aTet or lactose) was sufficiently repressed under non-inducing conditions to prevent Cas9-296 
mediated genome cleavage.  297 
Another recent study regenerated 630Δerm by deleting both ermB genes, as was done in 298 
this study, utilising the Cpf1 endonuclease instead of Cas9 22. However, this CRISPR-Cpf1 299 
mediated ermB deletion was performed in a lab strain of 630 and no whole genome 300 
sequencing of the subsequent mutants was reported. Hence, our 630Δerm* strain is preferable 301 
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for use in future studies as we have confirmed a lack of ancillary mutations relative to the 302 
NCTC 630 reference strain. 303 
Our developed CRISPR-Cas9 system was notably characterised by the presence in the 304 
cas9 coding sequence of a nucleotide insertion that resulted in the premature termination of 305 
the encoded product. Despite this, our system proved highly effective, suggesting that a 306 
functional Cas9 nucleases was still being produced. The most likely explanation for this 307 
phenomenon was that re-initiation of translation occurs at a downstream, internal AUG start 308 
codon that is preceded by a sequence reminiscent of a RBS sequence. The protein (trCas9) 309 
would, therefore, be foreshortened by some 87 amino acids from the N-terminus of the native 310 
Cas9 nuclease. As the deleted region encompasses a RuvCI nucleolytic domain 23 the variant 311 
Cas9 produced is most likely a nickase. Whilst nickase has reduced editing efficiencies 312 
compared to native Cas9, because their expression is less deleterious to the cell, larger 313 
numbers of primary transformants/ transconjugant cells are obtained which, upon subsequent 314 
passages, result in mutants. As a consequence, the final total number of mutants obtained in 315 
other clostridia has been shown to be greater in comparison to the use of native Cas9 13,15. 316 
Subsequent attempts to recreate plasmid pMTL431521 were repeated unsuccessfully, again 317 
resulting in the isolation of cas9 variants in which various rearrangements and deletions had 318 
occurred that obviated the isolation of a fully functional cas9 (data not shown). The most 319 
likely explanation for the repeated isolation of this variant is that the high expression of cas9 320 
when placed downstream of the strong Pthl promoter is detrimental to the E.coli host resulting 321 
in the selection of variants which no longer express a Cas9 nuclease with DSB activity.  322 
The emergence of inadvertent mutations that reduce cas9 expression underlines the 323 
importance of limiting the constitutive expression of these genes, particularly in the E.coli 324 
donor strain. Recently, a CRISPR vector for use in C. sporogenes was described 24 in which 325 
cas9 was placed downstream of the promoter of the C. spororgenes ferredoxin gene, Pfdx. 326 
Similar to Pthl, this is a strong, constitutive promoter 25. Closer inspection of the strategy 327 
employed reveals that the 5’end of the fragment carrying cas9 was not cloned at an 328 
appropriate position downstream of the RBS of the Pfdx promoter of the vector used, 329 
pMTL83151. Rather the region of DNA encoding the 5’-end of lacZα region of pMTL83151 330 
remained. This is predicted to result in the production of a polypeptide comprising some 331 
sixteen amino acids from LacZα (MTMITNSSSVPGDPLE) followed by a further 6 amino 332 
acids (WIRNTQ) derived from the out-of-frame fusion to the 5’-end of cas9, after which a 333 
TAG stop codon is encountered. The cas9 gene is not preceded by an appropriate RBS 334 
sequence. It is, therefore, highly likely that this vector exhibits Cas9 activity for the same 335 
reason as described here, through re-initiation of translation at a downstream, internal AUG 336 
start codon to produce trCas9.  337 
C. difficile 630 is resistant to a wide range of antibiotics including Em, tetracycline and β-338 
lactams, limiting the choice of markers which can be used in genetics studies. The previous 339 
generation of EmS derivatives of 630, 630Δerm and 630E, permitted the use of the ermB 340 
marker in ClosTron mutagenesis for the identification of successful intron insertion into the 341 
target gene. Whilst the development of CRISPR-Cas9 genome editing allows mutagenesis to 342 
be performed in wild-type strains, the availability of an EmS 630 strain will still find use in 343 
studies which require multiple antibiotic resistance markers or where an ermB marker is to be 344 
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used without risk of reversion to an EmR phenotype previously observed with 630Δerm at 345 
low frequencies 6. Here we present 630Δerm*, an EmS 630 strain which is sequence identical 346 
to the NCTC 13307 parental strain, except for the intended deletion within Tn5398.  347 
Our initial attempts at generating a SNP-free EmS strain of 630 were hampered by the 348 
presence of mutations in our laboratory stock of 630 (CRG 630) prior to the onset of this 349 
work, most notably the 21 bp deletion. Our stock of 630 was acquired from the Brendan 350 
Wren laboratory (LSHTM) in 2010, who had previously acquired it from the Mullany 351 
laboratory. A fresh stock of 630 was reacquired from LSHTM in 2018, from Lisa Dawson, 352 
and the region encompassing the deletion PCR amplified from the culture. No evidence for 353 
the presence of the deletion was evident from Sanger sequencing of the amplified DNA 354 
fragment. On receipt in 2010, the strain would have been used to prepare glycerol stocks 355 
which have been stored from that date at -80° C until used here. It would appear that the 356 
deletion variant arose during the sub-culture undertaken to create that stock.  357 
Since its isolation from a patient with severe pseudomembranous colitis in 1982 by Wust 358 
et al. 4, C. difficile 630 was supplied to Hachler, who in turn supplied this strain to Mullany, 359 
who then supplied it to Wren, from whom we obtained our CRG 630 strain. Mullany also 360 
deposited strains 630 and the EmS derivative 630Δerm with the NCTC culture collection 361 
(NCTC 13307) who then supplied 630 to the DSMZ collection (DSM 27543). Given the 362 
variants accumulated in our CRG 630 strain and the differences between published 630 363 
genomes, we reiterate our previous recommendation 11 that bacterial strains within laboratory 364 
collections are regularly re-sequenced. Furthermore, with the ever-decreasing cost of whole 365 
genome sequencing it is essential that this is performed after the generation of mutant strains 366 
to ensure no ancillary genomic variants have been acquired along the way. A similar 367 
recommendation was made in a recent review of C. difficile 630 reference genome sequences 368 
advocated the resequencing of all laboratory 630 strains to allow for the tracing of 630 369 
evolution, and drew parallels between the dissemination and propagation of 630 strains in 370 
laboratories and culture collections across the world to the E. coli long-term evolution 371 
experiment 26. 372 
 Traditional approaches to mutant generation by allelic exchange in clostridia, has been 373 
reliant on counter selection markers in a two-step selection process reliant on the initial 374 
isolation of single cross-over integrants followed by the isolation of the desired double cross-375 
over mutants. As a consequence, repeated passages through single colony isolations are 376 
required, a process that increases the chances of isolating ancillary genomic mutations. The 377 
use of CRISPR-Cas9 allows the direct selection of clonal populations which carry the desired 378 
mutant allele, reducing the number of passages and thereby the chances of isolating 379 
inadvertent mutants. Both approaches, however, can fall foul of the need to isolate mutants 380 
that have lost the plasmid used to create them. In many instances, this can require several 381 
passages through single colony re-streaks. As demonstrated here, the more passages that are 382 
undertaken, the greater the likelihood of selecting a derivative containing SNPs or Indels. In 383 
this respect, the number of passages used to cure the CRISPR-Cas9 vector employed to create 384 
the mutant should be wherever possible minimised.  385 
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 491 
Methods 492 
Bacterial strains and plasmids. All bacterial strains and plasmids utilised in this study are 493 
listed in Tables 1 and 2 respectively. E. coli was cultured in LB medium, supplemented 494 
where appropriate with chloramphenicol (25 μg.ml-1), at 37°C with horizontal shaking at 200 495 
rpm. C. difficile was cultured anaerobically at 37°C in an anaerobic MACS1000 workstation 496 
(Don Whitely, Yorkshire, UK) in BHIS (Brain Heart Infusion supplemented with yeast 497 
extract [5 mg.ml-1] and L-cysteine [0.1% w/v]) medium supplemented with d-cycloserine 498 
(250 μg.ml-1), cefoxitin (8 μg.ml-1) and thiamphenicol (15 μg.ml-1) or Em (10 μg.ml-1) where 499 
appropriate. Confirmation of pyrE truncation was performed by plating strain onto C. difficile 500 
minimal medium described previously 27, supplemented with uracil (20 μg.ml-1) and 5-501 
flouroorotic acid (4 mg.ml-1) where appropriate.  502 
 503 
Modularisation of the CRISPR-Cas9 vector. First, cas9 and Pthl from pMTLcas-pta were 504 
amplified using Pthl-F-XbaI and Cas9R-NotI, with the resulting PCR product digested with 505 
XbaI and NotI and cloned into a pMTL83151 backbone linearised with the same enzymes. 506 
Following Sanger sequence confirmation with CatP-R1, pyrE targeting sgRNA cassette was 507 
generated and inserted described below. Using pMTLcas-pta as a template, the ParaE promoter 508 
was amplified with sgRNA-F-XbaI and sgRNA-pyrE-sg3-SOE-R, with the latter primer 509 
containing the 20 nt pyrE targeting seed region as an overhang. Simultaneously, the sgRNA 510 
handle and its associated terminator were amplified using sgRNA-pyrE-sg3-SOE-F and 511 
sgRNA-R-MauBI-AscI primers, with the former containing the 20 nt pyrE targeting seed 512 
region as an overhang. Using the flanking sgRNA-F-XbaI and sgRNA-F-MauBI-AscI 513 
primers, these two PCR products were spliced via SOEing PCR using the overlapping seed 514 
region. The resulting spliced PCR product was digested with XbaI and AscI, and cloned in the 515 
Cas9 containing pMTL83151 vector described above (also digested with XbaI and AscI). 516 
Again, CatP-R1 was used for Sanger sequence confirmation of this intermediate vector, prior 517 
to insertion of the pyrE homology arm cassette, resulting in the final pMTL43151-CLAU-518 
pyrE vector. 519 
For homology cassette generation, primer pairs CLAU-pyrE-LHA-F-MauBI + CLAU-520 
pyrE-LHA-R, and CLAU-pyrE-RHA-F + CLAU-pyrE-RHA-R-AscI were used to generate 521 
the pyrE LHA and RHA, respectively. Following this, the flanking primers CLAU-pyrE-522 
LHA-F-MauBI and CLAU-pyrE-RHA-R-AscI were used to splice the homology arms, with 523 
the subsequent PCR product digested with MauBI and AscI. The digested homology arm 524 
cassette was cloned in a MauBI and AscI linearised backbone of the intermediate Cas9 and 525 
sgRNA containing pMTL83151 vector described above, to generate the final pMTL43151-526 
CLAU-pyrE vector. Following the identification of issues regarding MauBI digestion 527 
efficiency, the relevant primer pairs were adjusted in order to incorporate the AsiSI 528 
recognition site in place of the MauBI site, as detailed in Supplementary Table S4 . Final 529 
vector sequence confirmation was achieved using CatP-R1 and sgRNA-F-XbaI primers. 530 
 531 
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Having modularised the pMTLcas-pta into the pMTL40000 vector series as outlined in the 532 
results section, we next sought to modify this system for use in C. difficile via replacement of 533 
the ParaE promoter controlling sgRNA expression. Accordingly, the promoter region of tcdB 534 
was PCR amplified from C. difficile 630 genomic DNA using primer pair PtcdB_XbaI and 535 
PtcdB_SalI and cloned between XbaI and SalI restriction sites within pMTL431511-CLAU-536 
pyrE.  537 
For the deletion of a 3.6 kb fragment containing the erm1(B) and erm2(B) genes from 538 
Tn5398 an editing template for homologous recombination was generated. PCR primer pairs 539 
630erm_asiSI_LF1 & 630erm_LR1, and 630erm_RF1 & 630erm_ascI_RR1, were used to 540 
amplify 0.977 kb and 1.025 kb homology arms, respectively, from C. difficile 630 genomic 541 
DNA. These homology arms were fused together using splicing by overlap extension PCR 542 
(SOE-PCR) with primers 630erm_asiSI_LF1 and 630erm_ascI_RR1 and the resulting editing 543 
template cloned into pMTL431511-CLAU-pyrE between AsiSI and AscI restriction sites. To 544 
retarget the sgRNA submodule of the resulting vector, we identified 20-nucleotide guide 545 
retargeting sequences upstream of 5’-NGG-3 PAMs within the 3.6 kb chromosomal deletion 546 
fragment using the CRISPR guide design tool on Benchling (www.benchling.com) 20. Three 547 
guide sequences were selected with the highest on-target and off-target scores, across both 548 
DNA strands and incorporated into oligonucleotides with flanking 25-nucleotide regions of 549 
overlapping homology to the 3’-end of PtcdB and 5’-end of the sgRNA handle. These 550 
oligonucleotides were separately incorporated into SalI-linearized vector using HiFi DNA 551 
assembly (NEB), the assembly reaction products were transformed into E. coli DH5α and the 552 
Sanger sequencing confirmed vectors named pMTL431521-CDF-2008A, pMTL431521-553 
CDF-2008B and pMTL431521-CDF-2008C.  554 
Similarly, for generating truncated pyrE mutants in C. difficile 630 lacking 234 bp from 555 
the 3’ end of the gene, 1.338 and 1.026 kb homology arms were PCR amplified using primer 556 
pairs 630pyrE_asiSI_LF1 & 630pyrE_LR1, and 630pyrE_RF1 & 630pyrE_ascI_RR1, 557 
respectively, and fused together using SOE-PCR with primers 630pyrE_asiSI_LF1 and 558 
630pyrE_ascI_RR1. The resulting editing template was cloned between AsiSI and AscI sites 559 
of pMTL431521-CDF-2008A. Next, this vector was linearized with SalI as previously to 560 
allow replacement of guide targeting sequences using HiFi assembly with oligonucleotides 561 
pyrE1_HiFi, pyrE2_HiFi and pyrE3_HiFi generating the vectors pMTL431521-CDF-pyrE1, 562 
pMTL431521-CDF-pyrE2 and pMTL431521-CDF-pyrE3.  563 
 564 
CRISPR-Cas9 mutagenesis. CRISPR-Cas9 vectors were transferred to C. difficile 630 565 
strains via conjugation from E. coli CA434 donors as described previously 28. Thiamphenicol 566 
resistant transconjugant colonies appeared within 72 hours and were streaked to purity. 567 
Resulting single colonies were used as the template in colony PCR screens for the desired 568 
deletions using primer pairs annealing to chromosomal regions flanking the editing template 569 
sequences, Tn5398_sF1 & Tn5398_sR1 for 630Δerm* and CD630_pyrD_sF1 & 570 
CD630_0189_sR3 for 630Δerm*ΔpyrE. Colony PCR products were separated using agarose 571 
gel electrophoresis.  572 
Illumina Sequencing and bioinformatics. Genomic DNA was isolated from C. difficile 573 
overnight cultures using phenol-chloroform extraction and stored in Tris-HCl buffer (10 mM, 574 
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pH 7.8). C. difficile genomic DNA was sequenced using the Illumina MiSeq platform 575 
(DeepSeq, Nottingham, UK) using 500 bp V2 SBS chemistry. Analysis of the generated 576 
reads and identification of single nucleotide polymorphisms, insertions and deletions was 577 
performed using the Basic Variant Detection tool within CLC Genomics Workbench (version 578 
11.0.1) by mapping the trimmed Illumina paired-end reads to the reference sequences 579 
AM180355.1 3, CP010905.2 21, LN614756 29 or CP016318 30. Variants were detected with 580 
minimum coverage, count and frequency of 10, 2 and 70%, respectively, with base quality 581 
filter settings of neighbourhood radius = 5, minimum central quality = 20 and minimum 582 
neighbourhood quality = 15, applied.  583 
 584 
Development of heat-resistant CFU over 5 days. Sporulation assays observing the 585 
development of heat resistant CFU over 5 days were performed as described previously 31,32. 586 
Briefly, sporulation cultures, including a 630ΔermΔspo0A sporulation negative control 12, 587 
were grown in triplicate in BHIS broth for 5 days, with two 500 µl samples taken after 0, 24, 588 
48, 72, 96 and 120 hours. From each time-point, one sample was heat-treated (65 °C, 30 589 
minutes) whilst the other was incubated on the bench. Following incubations, samples were 590 
serially diluted from 100 to 10-7 in PBS and three 20 µl aliquots of each dilution were spotted 591 
onto BHIS agar supplemented with 0.1% taurocholic acid. After 24 hours, colonies were 592 
counted and CFU.ml-1 values determined.  593 
 594 
MIC determinations. Determinations of the minimum inhibitory concentration of C. difficile 595 
strains to Em was performed using the broth microdilution method described previously 33. 596 
Overnight C. difficile cultures were sub-cultured into pre-reduced BHIS broth supplemented 597 
with Em concentrations ranging from 0 to 64 ug.ml-1. After 24 hours incubation, OD600 598 
measurements were performed using a GloMax-Multi Microplate Multimode Reader 599 
(Promega, USA) and the MICs determined.  600 
 601 
 602 
Bacterial Strain Description Source 
E. coli TOP10 F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 araD139 Δ(ara leu) 7697 galU galK 
rpsL (StrR) endA1 nupG 
Invitrogen 
E. coli CA434 Conjugation donor Purdy et al. 28 
C. difficile 630 
(CRG856) 
Ribotype-012 wild-type (Zurich, Switzerland) P Mullany, UCL 
C. difficile 630 
(NCTC 13307) 
Ribotpye-012 wild-type, reference strain (Zurich, 
Switzerland) 
National Collection 
of Type Cultures 
(NCTC), Public 
Health England 
C. difficile 
630Δerm 
EmS derivative of C. difficile 630 lacking erm2(B) Hussein et al. 6 
C. difficile 
630Δerm*  
EmS C. difficile 630 strain lacking erm1(B) and 
erm2(B) 
This study 
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C. difficile 
630Δerm*ΔpyrE 
C. difficile 630Δerm* lacking 234 base-pairs from 3’-
end of the pyrE gene 
This study 
Table 1; List of bacterial strains utilised in this study.  603 
Plasmid Description Source 
pMTL83151 E. coli-clostridia shuttle vector with pCB102 replicon Heap et al. 19 
pMTLcas-pta CRISPR-Cas9 genome editing vector harbouring 
cas9 gene from Streptococcus pyogenes 
Huang et al. 14 
pMTL431511-
CLAU-pyrE 
Modular CRISPR-Cas9 vector targeting C. 
autoethanogenum pyrE  
This study 
pMTL431521-
CDF-2008A 
pMTL431511-CLAU-pyrE with TcdB promoter 
driving sgRNA expression, 2008A crRNA sequence 
and Tn5398 editing template 
This study 
pMTL431521-
CDF-2008B 
pMTL431521-CDF-2008A with 2008B crRNA 
sequence 
This study 
pMTL431521-
CDF-2008C 
pMTL431521-CDF-2008A with 2008C crRNA 
sequence 
This study 
pMTL431521-
CDF-pyrE1 
pMTL431521-CDF-2008A containing pyrE editing 
template and pyrE1 crRNA sequence 
This study 
pMTL431521-
CDF-pyrE2 
pMTL431521-CDF-pyrE1 with pyrE2 crRNA 
sequence 
This study 
pMTL431521-
CDF-pyrE3 
pMTL431521-CDF-pyrE1 with pyrE3 crRNA 
sequence 
This study 
Table 2; List of plasmids utilised in this study.  604 
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